FDA Drug Application (021501) for CAPITAL SOLEIL 15 by LOREAL USA

Back to FDA Applications sponsored by LOREAL USA

Application Number021501
Product Number001
FormCREAM;TOPICAL
Dosage2%;3%;10%
Product Market Status Over The Counter
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameCAPITAL SOLEIL 15
Active IngredientAVOBENZONE; ECAMSULE; OCTOCRYLENE

Active IngredientCount
List of drugs with Active Ingredient AVOBENZONE5
List of drugs with Active Ingredient ECAMSULE4
List of drugs with Active Ingredient OCTOCRYLENE4


Back to FDA Applications sponsored by LOREAL USA